SIRT5 and Myocardial fibrosis: The results showed a significantly smaller area of myocardial infarction and myocardial fibrosis in liver SIRT5 OE mice than in WT mice, suggesting a novel cardioprotective mechanism of SIRT5 through a liver-cardiac crosstalk mechanism.